ELUVIXTAMAB

Investigational

Approval Year

Substance Class	Protein Created by `admin` on `Wed Apr 02 03:14:58 GMT 2025` Edited by `admin` on `Wed Apr 02 03:14:58 GMT 2025`
Protein Type	BISPECIFIC ANTIBODY
Protein Sub Type
Sequence Type	COMPLETE
Record UNII	6Z4B5PJ4OP
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

ELUVIXTAMAB

Official Name

English

AMG-330

Preferred Name

English

IMMUNOGLOBULIN, ANTI-(HUMAN SIALIC ACID-BINDING IG-LIKE LECTIN 3) (HUMAN MONOCLONAL 1803MNGSSMABC SINGLE-CHAIN VARIABLE FRAGMENT VH1-(GGGGS)3-VL1) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS) FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN CD3 ANTIGEN .EPSI

Common Name

English

A CD33/CD3 BISPECIFIC T-CELL ENGAGER ANTIBODY FOR ACUTE MYELOID LEUKEMIA THERAPY

Common Name

English

eluvixtamab [INN]

Common Name

English

AMG330

Code

English

IMMUNOGLOBULIN SCFV-SCFV, ANTI-(HOMO SAPIENS CD33 (SIALIC ACID BINDING IG-LIKE LECTIN 3, SIGLEC3, SIGLEC-3, GP67, P67)) AND ANTI-(HOMO SAPIENS CD3E (CD3 EPSILON)), MONOCLONAL ANTIBODY SINGLE CHAIN, BISPECIFIC; IG SCFV-SCFV SINGLE CHAIN, ANTI-CD33 AND ANT

Common Name

English

ELUVIXTAMAB [USAN]

Common Name

English

Classification Tree Code System Code

FDA ORPHAN DRUG

691519